Mesoblast
Medicamentos celulares y productos de terapia celular alogénica.
Mesoblast fabrica medicamentos celulares y productos de terapia celular alogénica en sus operaciones de Melbourne. La empresa suministra sistemas de atención médica, laboratorios, socios OEM o clientes de exportación regulados en sus mercados primarios listados.
- Type
- brand seeking distribution
- Location
- Melbourne, Australia
- Founded
- 2004
- Website
- mesoblast.com
- Categories
- Suministros médicos y sanitarios
- Markets
- Australia, Estados Unidos, Alemania, Japón
Verified facts
- debarment-clear (green), checked 2026-08-12 OpenSanctions
- domain-registered (green), checked 2026-08-12 Domain registry record
- sanctions-clear (green), checked 2026-08-12 OpenSanctions
- lei-lapsed (amber), checked 2026-08-30 GLEIF global LEI register (golden copy)
Claimed certifications
- Good Manufacturing Practice
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)